Research / BLKB / Fundamental state Inspectable configuration
State dimensions Filing 0001280058-17-000006 General Corporate
Debt relative to revenue 0th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.debt_to_revenue
47.05% · OPTIONAL · VALID
Capex intensity 25th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.42% · OPTIONAL · VALID
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
21.02% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
14.56% · CORE · NOT_ENOUGH_HISTORY
Gross margin 75th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.gross_margin
53.58% · CORE · VALID
Operating margin 75th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.operating_margin
8.46% · CORE · VALID
R&D intensity 13th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
12.30% · OPTIONAL · VALID
SBC intensity 75th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
4.47% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 47 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 205.76%
Current 47.05%
Delta -158.70% Capex Intensity Increased
Previous 1.58%
Current 2.42%
Delta 0.84% Growth Decreased
Previous 15.27%
Current 14.56%
Delta -0.71% Margin Decreased
Previous 54.49%
Current 53.58%
Delta -0.90% Profitability Increased
Previous 7.40%
Current 8.46%
Delta 1.06% R And D Intensity Increased
Previous 12.30%
Current 12.30%
Delta 0.00% Sbc Intensity Decreased
Previous 4.82%
Current 4.47%
Delta -0.35% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.